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We report here on the characterization of a mouse
N-system amino acid transporter protein, which is in-
volved in the transport of glutamine. This protein of 485
amino acids shares 52% sequence homology with an N-
system amino acid transporter, mouse N-system amino
acid transporter (mNAT) and its orthologs. Because this
protein shares a high degree of sequence homology and
functional similarity to mNAT, we named it mNAT2.
mNAT2 is predominately expressed in the retina and to
a slightly lesser extent in the brain. In the retina, it is
located in the axons of ganglion cells in the nerve fiber
layer and in the bundles of the optic nerve. Functional
analysis of mNAT2 expressed in Xenopus oocytes re-
vealed that the strongest transport activities were spe-
cific for L-glutamine. In addition, mNAT2 is a Na1- and
pH-dependent, high affinity transporter and partially
tolerates substitution of Na1 by Li1. Additionally,
mNAT2 functions as a carrier-mediated transporter that
facilitates efflux. The unique expression pattern and
selective glutamine transport properties of mNAT2 sug-
gest that it plays a specific role in the uptake of gluta-
mine involved in the generation of the neurotransmitter
glutamate in retina.
Amino acid transporters play essential roles in a variety of
cellular processes, including uptake of nutrients, energy, and
chemical metabolism, detoxification, and specifically in neuro-
transmitter cycling (1). Mammalian amino acids transporters
identified to date belong to different gene families such as
cationic amino acid transporter, g-aminobutyric acid, and ex-
citatory amino acid transporter (2–4). Many of the gene fami-
lies identified thus far consist of multiple members that are
expressed in a tissue-specific manner. We recently cloned and
characterized a mouse N-system amino acid transporter,
mNAT,1 which is dominantly expressed in the liver (5). Two
orthologous genes of mNAT have been identified by us and
other groups, as human g17 and rat SN1 (5–7). The system N
amino acid transporter mostly mediates the transport of L-
glutamine, L-histidine, and L-asparagine across cell mem-
branes. Glutamine is the most abundant free amino acid in
both plasma and cerebrospinal fluid (8). Glutamine serves as a
precursor for other amino acids during protein synthesis. More-
over, transport of glutamine is essential for nitrogen metabo-
lism and synaptic transmission (9–12). System N has been
shown to be important in transporting glutamine for the con-
trol of nitrogen metabolism in the liver (9, 10). Furthermore, in
that organ, glutamine is a central intermediate in the detoxi-
fication of ammonia and the production of urea (13). Accord-
ingly, we have observed that there is a graded distribution of
mNAT expression from the central vein to the portal tract (5).
In the nervous system, glutamine serves as a precursor for
the synaptic transmitter, glutamate, both in glutamatergic
neurons in the brain (11, 12) and in the retina (14). The N-
system transporter, SN1, and the ASC system transporter,
ASCT2, are expressed in astroglial cells, and ASCT2 plays a
role in the export of glutamine from these cells (6, 15). Thus, it
is likely that either one or both of these two transporters
mediate the export of glutamine in glial cells. The glutamine
released by glial cells is then transported to glutamatergic
neuronal cells where glutamine is converted to glutamate (16,
17). The A-system transporter, GlnT/ATA1 has been reported
to be present in neurons of the central nervous system (18).
Hence, glutamine serves as a precursor for the generation of
glutamate in these cells by maintaining the glutamate-glu-
tamine cycle (19, 20).
To identify new member(s) of the N-system transporters, we
performed reverse transcription-PCR using primers based on
known N-system amino acid transporter sequences to screen
the RNAs isolated from mouse tissues. In this study, we report
the characterization of a mouse N-system transporter, mNAT2.
mNAT2 was found to be predominantly expressed in mouse
retina and brain. Its specific expression in the axons of gan-
glion cells and its selective transport properties suggest that
this transporter plays a key role in generation of glutamate and
in the maintenance of retinal homeostasis and function.
EXPERIMENTAL PROCEDURES
Materials—mMESSAGE mMACHINE for in vitro transcription was
obtained from Ambion (Austin, TX). The Marathon cDNA amplification
kit was obtained from CLONTECH (Palo Alto, CA). TRI reagent was
obtained from Molecular Research Center (Cincinnati, OH). 3H-Labeled
L-alanine, L-glutamine, L-glutamate, L-lysine, and L-histidine were pur-
chased from PerkinElmer Life Sciences (Boston, MA). Restriction en-
donucleases were from New England BioLabs (Revere, MA). Protease
inhibitors were obtained from Roche Molecular Biochemicals (Mann-
heim, Germany). Nitrocellulose membrane was purchased from
Schleicher & Schuell (Keene, NH), and Nylon transfer membrane-
Hybond H1 was from Oncor (Gaithersburg, MD). SDS-polyacrylamide
gel electrophoresis standards were from Bio-Rad (Hercules, CA). RNA
standards, oligo(dT) primer and Superscript II reverse transcriptase
were from Life Technologies, Inc. (Grand Island, NY). Micro BCA Pro-
tein Assay Reagent kit was from Pierce (Rockford, IL). Paraformalde-
hyde (16% stock solution) was from Electron Microscopy Science (Fort
* The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
“advertisement” in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted
to the GenBankTM/EBI Data Bank with accession number(s) AF184240.
¶ To whom correspondence should be addressed: Dept. of Biochemis-
try, Mail Code 7760, University of Texas Health Science Center, 7703
Floyd Curl Dr., San Antonio, TX 78229-3900. Tel.: 210-567-3796; Fax:
210-567-6595; E-mail: jiangj@uthscsa.edu.
1 The abbreviations used are: mNAT, mouse N-system amino acid
transporter; MeAIB, N-methylamino-isobutyric acid; ORF, open read-
ing frame; PCR, polymerase chain reaction; GST, glutathione S-trans-
ferase; FITC, fluorescein isothiocyanate; kb, kilobase(s).
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 276, No. 26, Issue of June 29, pp. 24137–24144, 2001
© 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org 24137
 at K
U
 Leuven U
niversity Library on M
arch 24, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Washington, PA). Tissue-Tek OCT compound was from Miles Scientific
(Naperville, IL). All other chemicals were from either Sigma Chemical
Co. (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA).
Cloning of the mNAT2 cDNA—The reverse transcription-PCR ap-
proach was utilized to identify new member(s) of the mNAT family.
RNAs was isolated from mouse brain, liver, kidney, bone, and skeletal
muscle using TRI reagent. To obtain the cDNA sequence, polyadeny-
lated RNA was isolated using a mRNA Separator kit (CLONTECH).
mRNA was converted to single-stranded cDNA by oligo(dT) and Super-
script reverse transcriptase (Life Technologies, Inc.). Several primer
pairs were designed based on the homology between the conserved
regions of the available N-system transporters, mNAT (AF159856), g17
(U49082), transporter in Arabidopsis (U39782) and transposase in
Pseudomonas stutzeri (AF039534). After PCR amplification over 30
cycles with annealing temperatures of 40 °C, one of the primer pairs
(sense primer, 59-GGTTGCGACAATGTCTGTTAGGAC-39; antisense
primer, 59-CGTGGGTCGTGAGATGTAGCAC-39) generated a 0.5-kb
DNA fragment from mouse brain cDNA. After sequencing (DNA Se-
quencing Facility, University of Texas Health Science Center, San
Antonio), this fragment showed homology to mNAT and g17. A mouse
brain cDNA was prepared using the Marathon-cDNA kit (CLONTECH)
according to the manufacturer’s recommendation. Based on the se-
quence obtained from this 0.5-kb PCR fragment, two unique primers
were designed: 59-TACACCATGCAGCCGGTTTC-39 to amplify the ad-
ditional 59 sequence and 59-GCAAGTTCATCTCAGATCGGGA-39 to am-
plify further the 39 sequence of this new gene. Subsequently, based on
the newly generated additional sequence, ten specific primers were
used to generate a complete ORF sequence of mNAT2.
Northern Blot Analysis—Northern blots were performed as described
(21). Total RNA was extracted from different tissues of adult mice using
TRI reagent. Thirty micrograms of RNA was loaded and separated by
agarose gel electrophoresis containing formaldehyde and transferred to
a Nylon membrane. The membrane was hybridized at 45 °C for 12 h in
a hybridization solution containing 50% formamide and 32P-labeled
cDNA probe corresponding to nucleotides 1–287 of mNAT2. The probed
membrane was washed in a high stringency condition, 0.13 SSC and
0.1% SDS at 63 °C for 1 h.
Antibody Preparation—Chicken anti-mNAT2 IgG antibody was pro-
duced using a glutathione S-transferase (GST)-tagged fusion protein as
described previously (21). A DNA fragment encoding amino acids 1–65,
which is distinguished from mNAT and its orthologs (5, 6), was pro-
duced by PCR using a mNAT2 DNA clone as a template (sense primer,
59-TCCCCCGGGACCGAATATGATGCATTTC-39; antisense primer, 59-
GGCCGAATTCGTCGCATTTCCTTTTCTC-39). This fragment was in-
serted into the expression vector, pGEX-2T. The recombinant fusion
protein was expressed in Escherichia coli, induced by isopropyl-thio-b-
D-galactoside, and isolated with GST beads. The purified fusion protein
was used to raise polyclonal antisera in chicken (Pocono Rabbit
Farm and Laboratory Inc., Canadensis, PA). The antisera generated
were affinity-purified by passage through two Sepharose CL-4B col-
umns, GST-conjugated and GST-mNAT2 fusion protein-conjugated,
respectively.
Membrane Protein Preparation and Immunoblot Analysis—Crude
membrane extracts were prepared from Xenopus oocytes and mouse
tissues, including retina, liver, brain, and testis as previous described
(5, 21, 22). Oocyte homogenates were centrifuged at 10,000 3 g at 4 °C
for 10 min to discard the yolk. The supernatant of oocyte homogenates
and mouse tissue homogenates were centrifuged at 100,000 3 g at 4 °C
for 30 min. The membrane pellet was collected, and protein concentra-
tion was determined using the Micro BCA Protein Reagent Assay kit
(Pierce). Twenty micrograms of protein were loaded and separated on a
10% SDS-polyacrylamide gel electrophoresis, and transferred to a ni-
trocellulose membrane. The membrane was probed with a 1:200 dilu-
tion of affinity-purified preimmune and anti-mNAT2 antibodies. The
primary antibody was detected using 1:1000 dilution of alkaline phos-
phatase-conjugated rabbit anti-chicken secondary antibody.
Immunofluorescence and Confocal Laser Microscopy—The immuno-
fluorescence detection of mNAT2 was performed as described previ-
ously (23). Oocytes and retinal tissue samples were fixed in 2%
paraformaldehyde for 2 h, incubated in 30% sucrose in phosphate
buffered saline at 4 °C overnight, embedded in OCT, and then frozen in
liquid nitrogen. Frozen sections (10-mm thickness) were fixed in acetone
at 220 °C for 5 min, incubated with blocking solution (2% normal goat
serum, 0.25% Triton X-100, 2% fish skin gelatin, and 1% bovine serum
albumin in phosphate buffered saline) for 30 min and then with affinity-
purified preimmune or anti-mNAT2 (1:100 dilution in blocking solu-
tion) at 4 °C overnight. The primary antibodies were detected by fluo-
rescein (FITC)-conjugated goat anti-chicken Ig (1:500 dilution) for 2 h at
room temperature. Mouse retinal sections were double-labeled with
propidium iodide (2 mM) and anti-mNAT2 antibody followed by FITC-
conjugated goat anti-chicken secondary antibody. The specimens were
analyzed using a confocal laser scanning microscope (model: Fluoview,
Olympus). FITC fluorescence was excited at 488 nm by an argon laser
and propidium iodide was excited at 543 nm with a HeNe-G laser. The
emission filters used were: BA505–525 for FITC fluorescence, BA610
for propidium iodide, and BA660 for phase-contrast.
Expression of mNAT2 in Xenopus laevis Oocytes—To prepare cRNA
for oocyte injection, cDNAs were synthesized by PCR and subcloned
between the 59- and 39-flanking sequences of the Xenopus b-globin gene
of a Xenopus expression vector as described previously (24). The primer
pairs used to amplify the entire ORF of mNAT2 were designed with a
restriction site EcoRI at the 59-end and HindIII at 39-end; sense primer,
59-ACGGAATTCAAGATGATGCATTTCAAAAGTGG-39; antisense
primer, 59-ATCGAAGCTTCAGTGGCCTTCGTC-39. PCR products were
purified and digested with EcoRI and HindIII before subcloning into the
Xenopus expression vector. The constructs were confirmed by sequenc-
ing. The plasmids were linearized with NotI and in vitro transcribed by
T7 RNA polymerase using mMESSAGE mMACHINE. Capped cRNA
was extracted with phenol/CHCl3, precipitated with ethanol as de-
scribed (24), resuspended in diethyl pyrocarbonate-treated H2O at a
concentration of 1.5–2.0 mg/ml and stored at 280 °C prior to use.
Transport Assays—Stage V–VI oocytes from Xenopus laevis were
dissected and injected with 50 nl of the synthetic cRNA or diethyl
pyrocarbonate-H2O as a control. After 3 days of incubation at 18 °C,
functional analyses were performed in groups of five to ten oocytes per
assay as described previously (25–27). Oocytes were rinsed briefly in
uptake buffer (KCl, 2 mM; MgCl2, 1 mM; CaCl2, 1 mM; HEPES, 10 mM;
and Tris, 50 mM) in the presence of 100 mM NaCl (Na1 buffer), 100 mM
choline chloride (choline1 buffer), or 100 mM LiCl (Li1 buffer). These
oocytes were transferred into a 24-well culture dish containing 2 ml of
uptake buffer and were incubated for 2–60 min at room temperature.
Amino acid transport activities were measured by incubating oocytes in
0.5 ml of uptake buffer in the presence of 50 mM L-amino acids plus
corresponding 3H-labeled L-amino acids as tracers for 15 or 30 min. The
oocytes were washed four times in cold uptake buffer. These oocytes
were lysed in 100 ml of 2% SDS, and the radioactivity accumulated by
each oocyte was measured with a scintillation counter (Beckman) in 10
ml of scintillation solution.
The specificity of mNAT2-mediated amino acid uptake was examined
using an amino acid competition assay. L-Glutamine uptake (50 mM)
was measured in the presence of 5 mM 20 non-radioactive L-amino acids
and MeAIB. The Na1 dependence and Li1 tolerance of L-glutamine
transport by mNAT2 were investigated using Na1 buffer, choline1
buffer, or Li1 buffer. The effects of extracellular pH on L-glutamine
uptake mediated by mNAT2 were investigated at pH 6.5–8.5 by adjust-
ing the Na1 buffer with Tris-base or hydrochloric acid as described (26,
27). L-Glutamine efflux was measured as previously described (28). An
average of nine injected oocytes was incubated for 30 min in Na1 buffer
containing 50 mM L-[3H]glutamine. After washing in Na1 buffer con-
taining 50 mM non-radioactive L-glutamine, oocytes were transferred to
300 ml of Na1 buffer or Na1 buffer containing 1 mM non-radioactive
L-glutamine. At each designated time, 200-ml samples were taken to
determine the levels of radioactivity and fresh 200 ml of Na1 buffer or
Na1 buffer containing 1 mM non-radioactive L-glutamine were added to
assume the volume size of the reaction. The readings from radioactivity
measurement were adjusted to compensate for the dilution factors. All
experiments were repeated at least three times, and the data collected
are presented as S.E.
RESULTS
Molecular Cloning of mNAT2 and Sequence Analysis—To
identify member(s) of N-system transporters, we used PCR
homology cloning (see “Experimental Procedures”). We
screened cDNA from various mouse tissues using conserved
primer pairs. One fragment of 0.5 kb was obtained from brain
tissue. This fragment showed 77% nucleotide identity to mNAT
(nucleotides 166–296), 78% to g17 (nucleotides 166–258), and
78% to SN1 (nucleotides 161–289), suggesting that this is a
new mouse amino acid transporter. Further cloning using
primers derived from this PCR fragment sequence generated a
complete ORF of the new gene, which encodes 485-amino acid
residues (GenBanky accession number AF184240). The align-
ment of amino acid sequence of mNAT2 with those of N-system
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transporters, mNAT, SN1, and g17, and A-system transport-
ers, GlnT/ATA1 and ATA2 is shown in Fig. 1. mNAT2 shares
52% homology with mNAT, SN1, and g17. The homologies
between mNAT2 and A-system transporters, GlnT/ATA1 and
ATA2 are 97 and 50%, respectively. The first seven transmem-
brane domains are highly conserved between N- and A-system
transporters whereas N-terminal regions are highly diverse.
Based on hydrophobicity analysis (PSORT version 6, Nakai file
server; TMPRED, Swiss, EMBNET; and BCM Search Launch-
er), mNAT2 like mNAT is a plasma membrane protein (cer-
tainty 5 87%,) with a high probability of having 10 transmem-
brane domains (Fig. 2A). As the deduced sequence lacks a
signal peptide, the long N- and the short C-terminal tails are
assumed to be in the cytoplasm (high probability score)
(Fig. 2B).
mNAT2 Is Predominately Expressed in Retina and
Brain—To elucidate the tissue-specific expression of mNAT2,
high stringency Northern blots of equivalent amounts of RNA
isolated from various tissues were probed with a labeled
mNAT2 DNA fragment. An abundance of ;8.5 kb was detected
in mouse retina and brain. Trace levels of mNAT2 expression
were detected in spleen, small intestine, and lung whereas
there was no detected hybridization in lens, testis, muscle,
liver, kidney, and heart (Fig. 3A). Based on the 39- and 59-
RACE sequencing and Northern blot results, there was a
0.1-kb non-coding sequence at the 59-end and a 7-kb non-coding
sequence at the 39-end in the extended transcript (8.5 kb).
Western blot analysis with an affinity-purified mNAT2-spe-
cific antibody revealed an immunoreactive protein band that
was consistent with the predicted molecular mass of Mr 52
kDaa on crude membrane fractions of brain (Fig. 3B, lane 2)
and retina (lane 3). There was no detectable mNAT2 expression
in testis (lane 4) and liver (lane 5). The specificity of this protein
band was further ascertained by the lack of detected immuno-
reactivity of the retinal sample by probing with preimmune
serum (lane 1). These results confirmed the observation from
the Northern blot that mNAT2 was predominantly expressed
in the retina and brain.
Differential Expression of mNAT2 in the Retina—Expression
FIG. 2. Hydrophobicity and inferred topology of mNAT2. A,
hydropathy analysis of mNAT2. The two lines in the hydrophobicity plot
represent the probability of the orientations: i3o represents the orien-
tation from cytoplasmic side to extracellular side; o3i represents the
opposite orientation. B, amino acid sequence and inferred structure of
mNAT2. The most probable transmembrane topology of mNAT2 was
deduced based on the high probability score (PSORT version 6). The
amino acids conserved with mNAT are shaded.
FIG. 1. Amino acid sequences align-
ment of the members of N- and A-sys-
tem transporters. The deduced amino acid
sequence of mNAT2 is aligned with N-sys-
tem transporters, mNAT (AF159856), SN1
(AF273025), and g17 (U49082), and A-sys-
tem transporters, GlnT/ATA1 (AF075704)
and ATA2 (AF249673) (GenBanky acces-
sion numbers are shown in parentheses).
Identical residues are shaded. Putative
transmembrane domains of mNAT2 are
marked in boldface and underlined. Gaps in
the amino acid sequence are marked with
dashed lines.
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of mNAT2 was detected in the retina with the aid of immuno-
fluorescence confocal microscopy. Based on the published his-
tological illustrations of mouse retina (29), the defined layers of
mouse retina in our preparation were visualized in the phase-
contrast image (Fig. 4A) and in the corresponding image of cell
nuclear staining (Fig. 4B). The immunofluorescence with spe-
cific antibody to mNAT2 demonstrates its predominant local-
ization to the axons of ganglion cells in the layer of nerve fibers
of the retina (Fig. 4C). Interestingly, the localization of mNAT2
expression is consistent with that of free glutamine, which has
been previously shown to occur at the highest levels in ganglion
cells and their axons (30, 31). To further confirm the expression
of mNAT2 in the nerve fibers of ganglion cells, we examined the
localization of mNAT2 in the optic papilla (optic disc) where
ganglion cell axons converge to form the optic nerve (Fig. 5).
mNAT2 was shown to be localized in the inner layer of the
retina and in the optic nerve (Fig. 5, A and B, low magnifica-
tion). The abundant expression of mNAT2 was clearly demon-
strated in the strands of nerve fibers near the optic papilla and
in the optic nerve bundles formed by axons of ganglion cells
(Fig. 5, C and D, high magnification). No expression of mNAT2
was detected in the connective tissues surrounding the optic
nerve (arrow). Together, our results from our functional anal-
ysis and expression pattern suggest that mNAT2 expressed at
the axon fibers of ganglion cells is likely to participate in the
uptake of glutamine in the glutamine-glutamate cycle (19).
mNAT2 Preferably Transports L-Glutamine, L-Histidine, and
L-Asparagine—To determine the functional role of mNAT, we
expressed mNAT2 in Xenopus oocytes, which is one of the
model systems most often used to study the properties of trans-
porters (5, 19, 24). Using an affinity-purified mNAT2 antibody,
expression of mNAT2 was detected by immunofluorescence and
immunoblot analysis as early as 24 h following cRNA injection.
Three days after injection, mNAT2 protein was mainly local-
ized in the oocyte plasma membrane, whereas positive signals
were undetectable with an affinity-purified preimmune anti-
body (Fig. 6A). The anti-mNAT2 antibody did not detect posi-
tive signals in oocytes injected with water (data not shown). By
Western blotting using mNAT2 antibody, a protein band, ’52
kDa was detected in mNAT2 cRNA-injected oocytes (Fig. 6B,
lane 1), which was undetectable in water-injected control oo-
cytes (lane 2). No immunoreactive bands could be detected in
mNAT2-expressing oocytes using preimmune antibody (lane 3).
The uptake of 3H-labeled L-alanine, L-glutamine, L-gluta-
mate, L-histidine, and L-lysine, representing groups of zwitte-
rionic, anionic, and cationic amino acids, was measured in
Xenopus oocyte system. Compared with control water-injected
oocytes, mNAT2-expressing oocytes exhibited uptake of L-glu-
tamine most strongly, followed by L-histidine and L-alanine. A
modest increase in L-lysine uptake was observed, whereas
there was no increase in L-glutamate uptake (Fig. 7A). These
results demonstrate that the most favorable substrate for
mNAT2 is L-glutamine followed by L-histidine and L-alanine
and suggest that mNAT2 has similar transporting substrate
selectivity as the other N-system transporters, mNAT, SN1,
and g17 (5–7).
L-Glutamine Transport by mNAT2 Is Not Competed by the
A-system-specific Substrate, MeAIB—Because there are sub-
strate overlaps among defined amino acid systems, especially
between systems A and N, a competition assay in the presence
of all 20 L-amino acids and the A-system-specific substrate,
MeAIB (2), was performed (Fig. 7B). As the most optimal sub-
strate for mNAT2, L-glutamine was selected as a model for the
competition assay. In this assay, the rate of uptake of L-gluta-
mine was determined in oocytes injected with mNAT2 cRNA in
the presence of 5 mM non-radioactive-labeled 20 L-amino acids
and MeAIB. L-Glutamine uptake was significantly inhibited by
the following amino acids, listed in order of inhibitory potency:
L-glutamine $ L-histidine $ L-asparagine $ L-methionine $
L-alanine $ L-serine $ L-cysteine. The A-system-specific sub-
strate MeAIB was unable to significantly block the transport of
glutamine, suggesting that mNAT2 is an N-system glutamine
transporter and is not an A-system transporter.
mNAT2 Is a Na1- and pH-dependent Low-affinity Trans-
porter and Facilitates Efflux of L-Glutamine Transport—To
characterize the transport properties of mNAT2, we examined
the Na1 dependence and tolerance for Li1 substitution of
mNAT2. In the presence of Na1 buffer, L-glutamine uptake into
oocytes expressing mNAT2 was significantly greater (close to
90-fold) than the uptake exhibited by the control non-express-
ing oocytes. Choline ion substitution for Na1 led to a significant
decrease in L-glutamine uptake when compared with uptake in
oocytes incubated in Na1 buffer. Replacement of Na1 by Li1
partially restored the stimulatory effect by Na1 (Fig. 8A).
These results demonstrate that L-glutamine uptake mediated
by mNAT2 is Na1-dependent and partially tolerates replace-
ment of Na1 by Li1, which is consistent with the properties
exhibited by N-system transporters as previously described (5,
25, 32).
Extracellular pH in the range between 6.5 and 8.5 affected
L-glutamine uptake mediated by mNAT2. The results showed
that uptake of L-glutamine exhibited a pH dependence increas-
ing from low to high pH (Fig. 8B). To analyze the effect of pH on
the transport rate and substrate affinity of mNAT2, the con-
centration dependence of L-glutamine uptake mediated by
mNAT2 at three pH conditions, pH 7, 7.5, and 8, was investi-
gated (Fig. 8C). At the lower concentration, the rate of uptake
was an incremental function of concentration, whereas at
higher concentrations, uptake was close to saturation. This
observation indicated that L-glutamine uptake in oocytes ex-
pressing mNAT2 behaved as a carrier-mediated transport. The
kinetic constants were determined: At pH 7, Km 5 2.40 6 0.7
mM and Vmax 5 395 6 66 pmol/min/oocyte; at pH 7.5, Km 5
0.89 6 0.3 mM and Vmax 5 430 6 92 pmol/min/oocyte; at pH 8,
Km 5 0.54 6 0.06 mM and Vmax 5 597 6 53 pmol/min/oocyte
(n 5 6). The results demonstrated that pH altered both Vmax
FIG. 3. mNAT2 mRNA and protein levels in mouse tissues. A,
Northern blot analysis of mNAT2 expression in different mouse tissues.
Thirty micrograms of total RNA from different mouse tissues were
hybridized with a DNA probe of mNAT2 under high stringency condi-
tions. Loading control of ribosomal RNA (28 S and 18 S) is shown
stained with ethidium bromide. The positions of known size standards
are shown on the left. B, immunoblot of crude membranes isolated from
tissues as labeled with 1:200 dilution of affinity purified anti-mNAT2
antibody (lanes 2–5). mNAT2 expression is detected in mouse retina
(lanes 3) and brain (lane 2), but not observed in testis (lane 4) and liver
(lane 5). Control Western blot with preimmune serum on a membrane
fraction of mouse retina (lane 1).
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and Km of the transport mediated by mNAT2. With the de-
crease in pH, the substrate affinity (Km) is decreased signifi-
cantly, whereas the transport rate (Vmax) is decreased to a
lesser extent. Compared with mNAT (5), mNAT2 has a rela-
tively higher substrate affinity (Km) and transport capacity
(Vmax).
System N transport mediates efflux, because it can be trans-
stimulated by its substrates (5, 33). We measured efflux of
L-[3H]glutamine in mNAT2-expressing oocytes to determine
whether the substrate affects efflux of L-glutamine. These oo-
cytes were prelabeled with L-[3H]glutamine and incubated in
Na1 buffer in the presence or absence of non-radioactive L-
glutamine. As expected, in the presence of external L-gluta-
mine, oocytes expressing mNAT2 showed significantly in-
creased efflux of L-[3H]glutamine, particularly within the first
2-min time points, as compared with control oocytes incubated
FIG. 4. Immunofluorescence detection shows that mNAT2 is localized to the axons of ganglion cells in the nerve fiber layer of
retina. A frozen section of adult mouse retina is shown as follows: A, phase contrast; B and C, double labeling with propidium iodide and
anti-mNAT2 antibody (1:200 dilution) followed by FITC-conjugated secondary antibody (1:500 dilution), respectively. The following retinal layers
are indicated: ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer;
NFL, nerve fiber layer; and ILM, internal limiting membrane. Bar, 20 mm. The glutamate-glutamine cycling process in the ILM/NFL/GCL layers
and the proposed involvement of mNAT2 are illustrated in the inset to the right. Glutamine that is synthesized by glutamine synthetase (GS) is
released by Mu¨ller (M) cells (16, 17). Notice that free glutamine is most abundant in NFL/GCL layers as shown by other investigators (30, 31).
mNAT2 mediates the transport of free glutamine into axons of ganglion (G) cells. In ganglion cells, glutamine is catalyzed by glutaminase (GM)
to glutamate resulting in regeneration of this neurotransmitter (16, 17). Glutamate released by ganglion cells is taken up by Mu¨ller cells to
maintain the glutamine-glutamate cycle.
FIG. 5. Expression of mNAT2 in the mouse optic nerve. The diagram shown in the inset to the left illustrates the optic papilla region in the
retina. A frozen section of adult mouse retina around this region was labeled with anti-mNAT2 antibody (1:200 dilution) followed by FITC-
conjugated secondary antibody (1:500 dilution). The images shown are as the following: A (phase-contrast) and B (fluorescence) at low magnifi-
cation. Bar, 100 mm. The magnified FITC fluorescence images of the portions of the tissue section indicated in A (arrowheads) are shown in C and
D. C1 and D1 are the corresponding phase-contrast images of C and D. The connective tissue surrounding optic nerve is indicted in D1 (arrow).
Bar, 10 mm.
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in the absence of external L-glutamine (Fig. 8D). These results
suggest that mNAT2, like N-system transporters, can function
as a mediator for the efflux of substrates.
DISCUSSION
In this study, we have characterized the second member of
the N-system amino acid transport family, mNAT2 expressed
in axons of retina ganglion cells. Sequence and functional anal-
yses show that mouse mNAT2 is related to the N-system trans-
porter, mouse mNAT and its orthologs, rat SN1 and human g17
(5–7). The degree of amino acid homology between mNAT2 and
mNAT is 52%. The greater degree of divergence between
mNAT and mNAT2 is in the N terminus of the transporter. In
contrast to mNAT, which has nine transmembrane domains,
the predicted topology of that mNAT2 suggests that it has 10
transmembrane segments, placing the N and C termini in the
cytoplasm.
The substrate selectivity of mNAT2 conforms to that of the
previously characterized N-system transport (32), which pre-
fers substrates with nitrogen on their side chains such as
L-glutamine, L-histidine, and L-asparagine. The previously
identified first members of the N-system transporter, mNAT
and SN1, indeed possess this transport selectivity (5, 6). How-
ever, it is not sufficient to classify the of amino acid transporter
systems solely on the basis of substrate selectivity. For a given
amino acid, multiple transport systems might be involved in its
transport across cell membranes. Although L-glutamine is a
preferred substrate for the N-system, other systems such as A
and ASC can also mediate Na1-dependent L-glutamine uptake
(34). Therefore, to generate a clear classification, other criteria
are required. Both systems N and A are characterized by their
pH dependence (5, 6, 32, 35). However, system ASC-mediated
transport is pH-insensitive (36). Because we characterize
mNAT2 as a pH-dependent transporter, it thus does not belong
to the ASC system. Although systems A and N share some
substrate overlaps, their preferred substrates are different.
System N is characterized by its high selectivity for L-gluta-
mine and L-histidine uptake (5, 6, 32, 35). System A, however
preferentially transports short, straight-chain amino acids
such as L-alanine, L-glycine, and L-cysteine (37, 38). Another
method to distinguish between these two systems is by the
amino acid and its related substrate transport competition
assay. It has been generally accepted that inhibition by MeAIB
and L-histidine can be used to define systems A and N, respec-
tively (2). Therefore, based on the unique features of these two
systems, we define the mNAT2 to be a system N instead of A
transporter. First, mNAT2 has a strong transport activity for
L-glutamine and L-histidine, the preferred substrates for N-
system. Second, the activity of L-glutamine transport medi-
ated by mNAT2 can be effectively inhibited by N-system
substrates such as L-histidine and L-asparagine but not by
MeAIB. Third, uptake of glutamine by mNAT2 can be par-
tially supported by Li1. In contrast, system A is not tolerant for
Li1 substitution for Na1 (5, 6, 27, 32). Finally, mNAT2 medi-
ates efflux of substrates, a distinct feature of system N that
differentiates it from system A (33). Taken together, the trans-
port properties suggest mNAT2 belongs to the N-system family
of transporters.
mNAT2 also shares sequence homology with the recently
identified A-system transporters, rat GlnT/ATA1 (18), rat
ATA2 (39), rat SA1 (40), and SAT2 (41). In fact, ATA2, SA1,
and SA2 are the same gene. mNAT2 has a very high degree of
FIG. 6. Expression of mNAT2 in Xenopus oocytes. A, immunoflu-
orescence of mNAT2. Frozen section of X. laevis oocytes 3 days after
injection with mNAT2 cRNA was immunolabeled with an affinity-
purified anti-mNAT2 antibody or preimmune serum and were exam-
ined by confocal microscopy at a scanning interval section of 0.5 mm
(Bar, 30 mm). B, Western blot analysis shows the expression of mNAT2
(arrowhead) in crude membranes from oocytes injected with mNAT2
cRNA (lanes 1 and 3) and water (lane 2) using anti-mNAT2 antibody
(lanes 1 and 2) or preimmune antibody (lane 3).
FIG. 7. Amino acid uptake and competition analyses. A, amino
acid uptake rates in mNAT2-expressing oocytes against control, non-
expressing oocytes. L-Alanine, L-glutamine, L-glutamate, L-histidine,
and L-lysine uptake was measured in uptake buffer containing 50 mM
3H-labeled amino acid and incubated for 30 min (n 5 7). B, competitive
inhibition by 20 L-amino acids and MeAIB on the uptake of 50 mM
[3H]glutamine in Na1 uptake buffer (n 5 6). The percentage values
after subtracting controls injected with water are presented as 50 mM
L-glutamine uptake, defined as 100%. *Q, L-glutamine uptake in the
absence of non-labeled amino acids; *Me, MeAIB. All data are presented
as mean 6 S.E.
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sequence identity to GlnT/ATA1, suggesting that mNAT2 is
likely the mouse ortholog of rat GlnT/ATA1. Interestingly,
mNAT has a higher sequence identity to N-system transporters
than to A-system transporters (52% versus 50%), suggesting
that mNAT2 is more closely related to system N transporters.
Similar to mNAT2 expression in the retinal ganglion cells,
GlnT/ATA1 is expressed only on neurons and is absent from
astrocytes (18). In contrast to mNAT2 as an N-system trans-
porter, GlnT/ATA1 is reported to be a member of A-system
transporter family. In the reported substrate competition assay
of GlnT/ATA1, uptake of L-glutamine is dramatically inhibited
by L-histidine, but only weakly inhibited by the A-system-
specific substrate, MeAIB (18). This result suggests that, in
contrast to the previous interpretation (18), this functional
feature of GlnT/ATA1 matches N-system instead of the A-sys-
tem transport.
We have identified the predominant expression of mNAT2 in
the retina and brain. In the retina, mNAT2 is predominantly
localized in the nerve fibers of ganglion cells. As illustrated in
the insets in Figs. 4 and 5, the nerve fiber layer is composed
almost entirely of the axonal projections of the ganglion cells.
These axons are aggregated into nerve fiber bundles that pass
through the arcades formed by the columns and footplates of
Mu¨ller cells (42) and converge to form the optic nerve. The
internal limiting membrane layer located adjacent to ganglion
axon fibers consists mostly of the basal lamina of Mu¨ller glial
cells. Mu¨ller cells are known to uptake glutamate, and inter-
estingly, the glutamate transporter L-glutamate/L-aspartate
transporter has been identified in these cells (43). There, glu-
tamate is converted into glutamine by glutamine synthetase
and the newly synthesized glutamine is released (16, 17). Two
glutamine transporters, SN1 and ASCT2 are expressed in as-
troglial cells and play a role in the export of glutamine from
these cells (6, 15). Thus, it is likely that either or both of these
two transporters mediate the export of glutamine in Mu¨ller
glial cells. The released glutamine by Mu¨ller cells is then trans-
ported to glutamatergic ganglion cells where glutamine is con-
verted to glutamate via glutaminase (16, 17). Hence, glutamine
serves as a precursor for the generation of glutamate in these
cells (19, 20). In the previously reported studies using a gluta-
mine immunoreactivity assay, the presence of free glutamine
was most abundantly identified in glutamatergic ganglion cells
and their axons in comparison to all other retinal cells (30, 31).
Remarkably, the localization pattern of glutamine in the retina
matches that of mNAT2 expression. Therefore, based on spe-
cific expression pattern and transport function, our results
suggest that mNAT2 transports free glutamine into ganglion
cells for generation of the glutamate used in neuronal trans-
mission. Further studies will shed light on the function and
regulation of mNAT2 in retinal physiology and pathology.
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